The Fed is expected to cut rates Wednesday, but it is unlikely to tell markets what they want to hear on future rate cuts.Market Insiderread more
The trade war between the United States and China has lasted for more than one year — and a resolution is nowhere in sight.World Economyread more
Mortgage applications to purchase a home increased 6% for the week and were a strong 15% higher annually.Real Estateread more
Pelosi said Trump should not have tried to address China's trade practices in a way that opened Americans up to financial pain.Politicsread more
Corporate buyback trades are ripe for being picked off by high speed firms, effectively siphoning millions of dollars from the companies.Marketsread more
Here's CNBC review of the Apple Watch Series 5, which makes a step forward with an always-on display and a useful compass that can help you find your way on Apple Maps.Technologyread more
On Sept. 18, Capital One and Walmart announced the launch of the Capital One Walmart Rewards Credit Card Program, which offers two new cobranded credit cards. Here's a break...Moneyread more
FedEx is gearing up to report earnings after the bell Tuesday. Here's what to expect.Trading Nationread more
DoubleLine CEO Jeffrey Gundlach believes the bottom for interest rates is in for 2019.Marketsread more
TransferWise posted an annual net profit of £10.3 million on revenues of £179 million.Technologyread more
In an apparent setback for Prime Minister Benjamin Netanyahu, exit polls show the Israeli leader has fallen short of securing a parliamentary majority with his hard-line...World Newsread more
Private-equity firm New Mountain Capital's Avantor will but VWR Corp. for about $4.38 billion, creating a global lab equipment giant supplying everything from beakers to microscopes to the health-care and technology industries.
The deal combines Avantor's strength in manufacturing and its presence in emerging markets with VWR's distribution network in the Americas and Europe, the companies said.
Avantor, formed in August 2010 when New Mountain Capital purchased the business from Covidien, manufactures materials and chemicals for the biopharma industry.
VWR, a company that traces its roots to the California Gold Rush in the 1850s, was bought by Madison Dearborn Partners in 2007 and went public in October 2014.
Avantor's offer of $33.25 per share in cash represents a discount of 2.3 percent to VWR's Thursday close. VWR's shares were down 3.4 percent at $32.90 before the bell on Friday.
The company's shares have risen 19.4 percent since May 2, the day before the Wall Street Journal first reported the companies were nearing a deal.
The companies said the deal reflects an enterprise value of about $6.4 billion.
For New Mountain Capital, the deal adds heft to its health-care portfolio, which includes companies ranging from contact lens supplier ABB Optical to medical data firm
"This may be a strategic acquisition for New Mountain, in line with a "deep dive" strategy where it aims to build a portfolio presence in a few niche sectors, including health care," William Blair's Amanda Murphy wrote in a client note on Thursday.
Avantor Chief executive Michael Stubblefield will lead the combined company, while New Mountain Capital will continue to be the lead shareholder, the companies said on Friday.
Goldman Sachs, Jefferies and Barclays are the financial advisers to Avantor, while Simpson Thacher & Bartlett is the legal adviser.
Bank of America/Merrill Lynch advised VWR, while Kirkland & Ellis was the legal adviser.
CORRECTION: This story was updated to show VWR was bought by Madison Dearborn Partners, not Madison Capital Partners.